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Quantitative constraint-based 
computational model of tumor-to-
stroma coupling via lactate shuttle
Fabrizio Capuani1, Daniele De Martino1,2, Enzo Marinari1,4,* & Andrea De Martino1,2,3,*
Cancer cells utilize large amounts of ATP to sustain growth, relying primarily on non-oxidative, 
fermentative pathways for its production. In many types of cancers this leads, even in the presence 
of oxygen, to the secretion of carbon equivalents (usually in the form of lactate) in the cell’s 
surroundings, a feature known as the Warburg effect. While the molecular basis of this phenomenon 
are still to be elucidated, it is clear that the spilling of energy resources contributes to creating a 
peculiar microenvironment for tumors, possibly characterized by a degree of toxicity. This suggests 
that mechanisms for recycling the fermentation products (e.g. a lactate shuttle) may be active, 
effectively inducing a mutually beneficial metabolic coupling between aberrant and non-aberrant 
cells. Here we analyze this scenario through a large-scale in silico metabolic model of interacting 
human cells. By going beyond the cell-autonomous description, we show that elementary physico-
chemical constraints indeed favor the establishment of such a coupling under very broad conditions. 
The characterization we obtained by tuning the aberrant cell’s demand for ATP, amino-acids and 
fatty acids and/or the imbalance in nutrient partitioning provides quantitative support to the idea 
that synergistic multi-cell effects play a central role in cancer sustainment.
At heart, a cell’s energetic problem consists in selecting how to process nutrients (say, glucose molecules) 
into chemical energy (adenosine 5′ -triphosphate, ATP) that will then be transduced into useful forms of 
mechanical or chemical work. Rapid cellular growth, in specific, requires high rates of macromolecular 
biosynthesis and of energy production, which presupposes (a) fast ATP generation, and (b) tight control 
of the cell’s redox state, i.e. that the ratio between the levels of electron donors and acceptors stays in 
a range that guarantees functionality. Most often, molecular oxygen is the primary electron acceptor in 
cells, playing a central role in the electron transfer chain (ETC) that constitutes the main ATP-producing 
mechanism in cells. When a glucose molecule enters the cell, it is normally metabolized by glycolysis, 
a highly conserved reaction pathway that converts each glucose anaerobically into two molecules of 
pyruvate, with the concomitant production of 2 ATPs. In presence of oxygen, cells can operate the ETC, 
which begins with the conversion of pyruvate into acetyl-coenzyme-A (acetyl-CoA). The reaction path-
ways responsible for the subsequent production of ATP (and of many macromolecular precursors like 
amino-acids) are the Tricarboxylic Acid (TCA) cycle and Oxidative Phosphorylation (OXPHOS). These 
complex groups of reactions (roughly 100 processes altogether in the bacterium E. coli) are able to gen-
erate the largest energy yield in terms of molecules of ATP produced per glucose molecule intaken (up 
to 36, adding to the 2 given by glycolysis), and release carbon dioxide as a waste product. In absence of 
oxygen, however, cells cannot rely on the ETC and the ATP yield of glycolysis (2) is to a good approx-
imation all the energy they can generate. In such conditions, the pyruvate obtained from glycolysis is 
then reduced to other carbon compounds (e.g. acetate, ethanol, lactate) that are normally excreted in 
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variable amounts. The conversion of pyruvate to lactate, is carried out by a single reaction catalyzed by 
the enzyme lactate dehydrogenase (LDH).
The energy-generating strategies just described are, in a sense, the two extremes, and cells usually 
operate mixtures of the two even in presence of oxygen, leading to ATP yields below the theoretical max-
imum of 38 (typically around 30). However, fast proliferating cells normally display high rates of glucose 
intake and produce ATP anaerobically even in the presence of oxygen, thereby spilling potentially useful 
carbon and energy resources. A hint about why a large glucose influx may favor the use of lower-yield 
pathways is provided by the fact that processing high glucose fluxes via glycolysis requires high rates of 
production of adenosine 5′ -diphosphate (ADP) and of NAD+, via oxidation of NADH. The simplest way 
to convert NADH back into NAD+is by reduction of pyruvate to lactate via LDH. Therefore sustaining 
high rates of glucose metabolization may imply lactate overflow. This however seems to suggest that a 
cell with a large glucose intake should always prefer to generate energy by glycolysis. Therefore, different 
constraints (physical, regulatory, thermodynamic, etc.) may be at work in the selection of a cell’s energetic 
strategy1. We note that recent high-throughput studies of the compounds secreted by growing bacteria 
in controlled environments (the so-called exo-metabolome) uncovered that, besides the standard outputs 
of overflow metabolism, a previously unsuspected diversity of molecules accompanies the excretion of 
carbon equivalents2.
Likewise, aerobic glycolysis with lactate overflow (a.k.a. Warburg effect) is found to occur in many 
types of cancers3,4, although it cannot be considered as a necessary signature of malignancy5. In order 
to explain its predominance at the molecular level, several ideas have been pursued, from structural or 
genetic abnormalities in the mitochondria6, to the roles played by the hypoxia-inducible factor (HIF)7 
and by a specific isoform of the glycolytic enzyme pyruvate kinase8, to seemingly unrelated genetic events 
leading to the increase of glucose transporters and the loss of growth control in cancer cells9. The search 
for a molecular basis of the Warburg effect has given momentum to the idea that treatments targeting the 
simpler energy-producing apparatus of a cell (as opposed to its complex and not entirely known genetic 
profile) carry a higher potential than gene-based therapies10. Unluckily, our understanding of cancer 
metabolism is still largely incomplete11,12, and research on the role of metabolism in tumor genesis and 
progression is currently undergoing a major revival13.
Cell-autonomous models of cellular metabolism based on genome-scale reconstructions of the under-
lying network of metabolic reactions have been widely studied, proving effective in explaining the origin 
of overflow metabolism in different contexts. Constraint-based approaches like Flux-Balance Analysis 
(FBA), for instance, have shed light on the roles that different types of constraints may play in driving 
the selection of energetic strategies towards aerobic glycolysis. An interesting and intuitively appealing 
suggestion is put forward by the macromolecular crowding scenario14, according to which enzymes car-
rying out energy-efficient pathways can at most occupy a fraction of the intracellular volume (e.g. the 
mitochondria in eukaryotes). Because reactions are assumed to be enzyme-limited, the activity of aerobic 
pathways will necessarily level out once all deputed enzymes work at full speed, while that of glycolysis 
may still increase. These models are indeed able to predict carbon excretion by unicellulars15 as well as 
the Warburg effect in cancer cells14,16. Many issues however deserve further analysis.
One in particular concerns the fact that cellular waste products such as lactate tend to deteriorate 
the extracellular environment, so that the sustainability of aerobic glycolysis depends crucially on the 
possibility that such a pollution is remediated within cancer’s microenvironment. This raises questions 
about the role of tumor-stroma metabolic interactions. Tumors are universally characterized by a marked 
upregulation of glucose transporters9,17, which allows them to largely surpass their non-aberrant (stro-
mal) neighbors in the competition for nutrients. As a consequence, stromal cells must adjust their ener-
getics in ways that have only started to be analyzed18.
Lactate exchanges are increasingly being recognized to play an important role in this respect. In a 
scenario that has been characterized by genetic signatures over the past few years, tumor-derived lactate 
can be taken up by glucose-starved cancer-associated fibroblasts (CAFs)19, which would then both help 
their own survival and foster cancer’s aberrant growth by sanitizing the environment. Here we present a 
quantitative in silico analysis of the above mechanism. Our results confirm that tumor-to-stroma lactate 
shuttling appears as a robust consequence of basic physical and chemical constraints, in a manner that 
is largely independent of (i) the metabolic function (e.g. energy production, amino-acid synthesis, fatty 
acid synthesis, etc.) that aberrant cells strive to maximize and, perhaps more surprisingly, (ii) of the 
degree to which they manage to maximize it. The core of our conclusions can already be reached through 
a highly simplified model of metabolism that captures the bare essential features of the mechanism. The 
intuition is then validated on a large-scale model of catabolism based on recent reconstructions of the 
human reactome. After characterizing the network at the cell-autonomous level, we consider a system 
formed by two such networks sharing the same glucose supply, focusing on the case in which one cell 
aims to maximize a growth-related objective function (e.g. energy production) with the other subject to 
a simple ATP maintenance constraint. The emerging scenario is studied by tuning the ‘degree of maxi-
mization’ by the aberrant cell through a rigorous sampling scheme that provides a statistically significant 
description of all feasible metabolic phenotypes compatible with the constraints. Lactate overflow and 
functional tumor-stroma coupling appears robustly upon maximizing production of ATP as well as of 
several biomass precursors.
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It is important to stress that a tumor-to-stroma coupling, while compatible with the observation that 
the vast majority of cancer cells display glycolytic metabolism, is not the only lactate-based shuttling 
postulated to be relevant for tumor progression (see e.g.20). Other mechanisms and their relation to the 
current study are outlined in the Discussion.
The remainder of the manuscript is organized as follows. The Results section begins with a brief 
summary of a stylized single-cell model of aerobic glycolysis presented in14, where it is shown how a 
crowding constraint can divert ATP production from oxidative phosphorylation to fermentation. The 
simple model is then extended to two cells whereby the extent of lactate shuttle is computed analytically. 
A large scale metabolic network of the human core metabolism (HCCN) is then introduced. A rigorous 
sampling of the metabolisms produced by HCCN confirms the possibility of cell coupling by means of 
lactate shuttle between a cancer cell and a stromal cell. The rigorous samplings allows us to compute the 
correlation coefficients among the fluxes of the cancer and stromal cell. In the Discussion section, exper-
imental evidences for lactate shuttle are presented and, finally, physiological implications and possible 
experimental validation of the results are discussed.
Results
Metabolic fluxes and crowding constraint in a minimal cell-autonomous model. Our starting 
point is the highly simplified cell-autonomous model defined in14, in which lactate secretion is related 
to an ad hoc constraint limiting volume available for energy production in cells that maximize the ATP 
output flux. In particular, when ATP demands exceed the volume allocated for ATP production, the 
cell produces ATP also through fermentation. In the model of Vazquez et al., a cell is characterized by 
a glucose intake flux UG,in, a glycolytic flux fglyc (yielding two pyruvate molecules per intaken glucose) 
and an overall mitochondrial OXPHOS flux fox that transforms pyruvate into energy (a table summa-
rizing the most relevant variables defined here is given as Table S1). Alternately, pyruvate can be turned 
into lactate by lactate dehydrogenase (LDH), with flux fLDH. Lactate can then be expelled from the cell 
so as to avoid acidification. Mass balance and steady state conditions impose that metabolite levels do 
not change in time, so that, for example, the net production and consumption fluxes of pyruvate must 
compensate, implying
f f f2 0 1glyc ox LDH− − = , ( )
(note that, to make the subsequent analysis simpler, our algebra differs slightly in numerical pre-factors 
from the one given in14. The overall picture is however completely equivalent). The glycolytic flux is in 
turn limited by the flux UG that supplies glucose to the system, so that UG,in ≤ UG, while under mass 
balance UG,in = fglyc. The crowding constraint is implemented as Vglyc + Vox + VLDH ≤ VATP, where VATP rep-
resents the cell volume devoted to ATP production, whereas Vglyc, Vox, and VLDH are the volumes taken 
up by the glycolytic, OXPHOS, and LDH enzymes, respectively. Introducing the constants aglyc, aox, and 
aLDH representing the volume occupied per unit of ATP production by glycolytic, OXPHOS and LDH 
enzymes, respectively, this can be re-cast as14
a f a f a f 2glyc glyc ox ox LDH LDH ATP+ + ≤ Φ , ( )
where Φ ATP is the volume fraction available for ATP production in each cell. Using (1), one obtains
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We shall adhere to14 in employing the empirical estimates aglyc ≃ 3 × 10−3 (min/mM), aLDH ≃ 4.6 × 10−4 
(min/mM), aox ≃ 2 × 10−1 (min/mM), and Φ ATP = 0.4. Equation (3) represents the “crowding constraint”, 
amounting to a global constraint to the overall flux of metabolites the cell can invest in ATP production. 
To be consistent with14, we derived the crowding constraint on fluxes by limiting the volume fraction 
devoted to energy production, but the constraint (3) might as well be derived by limiting the amount of 
proteins (see, e.g.16).
To assess the amount of ATP produced by these fluxes, we consider that fglyc generates 2 ATPs and 2 
pyruvates per glucose molecule, and that fox creates 18 ATP molecules from each pyruvate. The conver-
sion of pyruvate to lactate does not generate any ATP and it only ensures that glycolysis can continue by 
regenerating NADH to NAD. The overall flux of ATP production is finally given by
f f f2 18 4ATP glyc ox= + . ( )
Vazquez et al.’s results can be summarized as follows. Neglecting (3), ATP production is maximized 
when fglyc = UG, fox = 2fglyc = 2UG, and fLDH = 0, i.e. when all available glucose is taken up by the cell and 
used in OXPHOS. This solution still holds if (3) is satisfied, i.e. as long as
a a U2 5ox glyc G ATP( )+ ≤ Φ . ( )
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If however UG > Φ ATP/(2aox + aglyc) ∫ uG, then the cellular resources available for high-yield energy 
production pathways has been exhausted and ATP synthesis is no longer limited by glucose but by 
intracellular resources (either volume or proteins production capacity). Its maximization now requires 
that the glucose flux exceeding the possibility of processing by OXPHOS is diverted towards LDH. The 
maximum ATP production flux and the corresponding lactate flux for this case can be obtained by 
inserting fLDH = 2UG − fox into (3) with the constraint saturated. One gets
f
U u
U u U u
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a a
0 if
if
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where υG = Φ ATP/(2aLDH + aglyc). Because of mass balance, fLDH also equals the lactate excretion flux so 
that the Warburg effect is described by (6), which shows the existence of a threshold glucose intake above 
which lactate is secreted.
Metabolic fluxes in a minimal model of two cells coupled via a lactate shuttle. Let us now 
consider two replicas of Vazquez et al.‘s cell and assume that the two cells can interact via the exchange 
of lactate, which, in particular, can be intaken and used as an alternative carbon source through reverse 
LDH (catalyzing the conversion of lactate back to pyruvate). For sakes of simplicity, we distinguish 
between a donor cell (‘don’, which can only excrete lactate) and an acceptor cell (‘acc’, which can both 
excrete and import lactate) (see Fig. 1). In order to avoid starvation, we furthermore impose that both 
cells generate a minimum flux f TPA
min of ATP, i.e.
≥ , ∈ , ( ),f f i {acc don} 8iATP ATP
min
where the ATP production flux is given by (4), namely
= + ∈ , . ( ), , ,f f f i2 18 {acc don} 9i i iATP glyc ox
As shown in the beginning of the previous section, when fglyc = UG and fox = 2UG cells can extract the 
maximum ATP from a single glucose molecule, i.e., fATP,i = 38UG. We observe that, in order to satisfy (8), 
the overall glucose supply to the system composed of two cells should satisfy
U
f
u
2
38
2 10GG
ATP
min
0≥ ≡ , ( ),
which defines uG,0 as the minimum glucose supply flux that can prevent cellular starvation. Denoting as 
UG,don the amount of glucose available to the donor cell, if the donor cell maximizes ATP production, its 
flux organization will match the one found above for a single cell. It is useful to distinguish two limiting 
cases:
(a) If the donor cell employs OXPHOS exclusively, which happens when 2uG,0 ≤ UG ≤ uG + uG,0, we have 
UG,don = UG − uG,0 and UG,acc = uG,0. In other words, the donor cell takes up all of the available glucose 
except for the amount necessary for the survival of the acceptor cell. In these conditions, the acceptor 
cell’s survival is guaranteed by glucose availability.
(b) At the other extreme, if the acceptor cell can survive even using exclusively the lactate excreted by 
the donor cell, all glucose is intaken by the donor cell, so that UG,don = UG and UG,acc = 0. This happens 
when f f 18LDH don ATP
min≥ /, , or
U
f
u
18 11G
ATP
min
ox
Gα
≥ + .
( )
In intermediate situations, the amount of glucose intaken by the acceptor cell gradually decreases 
from uG,0 to 0 as it increasingly uses lactate to produce pyruvate and thus ATP. In such cases, the oxi-
dative pathway of the acceptor cell is fed by both glucose and lactate fluxes as fox,acc = 2fglyc,acc + fLDH,don, 
which, via mass balance, implies (see (9))
= + = + . ( ), , , , ,f f f U f38 18 38 18 12ATP acc glyc acc LDH don G acc LDH don
To obtain simpler expressions, it is useful to introduce the shorthands
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u u u 13G 1 G 0 G= + , ( ), ,
u
f
u
18 14G 2
ATP
min
ox
Gα
= + ,
( ),
and Δ UG for the amount of glucose rerouted from the acceptor cell to the donor cell, so that
U u U
U U u U 15
G acc G 0 G
G don G G 0 G
= − ∆
= − + ∆ . ( )
, ,
, ,
Substituting UG,acc and imposing minimal ATP requirement in (12), we obtain
f U38
18 16LDH don G
= ∆ . ( ),
Since the donor cell maximizes ATP production, we obtain a second expression for fLDH,don as a func-
tion of Δ UG by substituting UG,don: in (6)
f U u U u U uLDH don ox G don G ox G G 0 G Gα α= ( − ) = ( − + ∆ − )., , ,
This, combined with (16), determines the extra amount of glucose available to the donor cell
Figure 1. Schematic representation of the minimal model of two cells coupled via a lactate shuttle. Two 
cells (lactate donor and acceptor, respectively) share glucose as an energy source. Glucose is partitioned 
according to the fluxes fglyc,don and fglyc,acc, which convert one internal glucose molecules to two pyruvate 
molecules producing two ATP molecules. Pyruvate can then undergo oxidative phosphorylation (with the 
irreversible fluxes fox,don and fox,acc, giving 36 more ATP molecules) or LDH (with fluxes fLDH,don and fLDH,acc, 
by which lactate (L) is obtained). Lactate is for simplicity assumed to be secreted upon production. If both 
cells produce lactate, no coupling sets in, unless due to competition for nutrients under glucose limitation. If 
however the donor cell secretes lactate, the acceptor cell may intake it to replace glucose whenever its access 
to the latter is limited (e.g. because the donor cell’s glucose intake is large). In such cases a lactate shuttle 
will effectively couple the metabolisms of the two cells.
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Expression (17) is valid if uG,1 < UG ≤ uG,2. For UG ≤ uG,1 one has Δ UG = 0, while when UG > uG,2 
Δ UG = uG,0. We can therefore summarize the fluxes for the donor cell as
α
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Because the donor cell uses up most of the glucose, the acceptor cell stays at the minimum ATP 
production rate fATP
min for UG ≤ uG,2. In this regime, the fluxes of the acceptor cell are fixed and can be 
derived from the ones of the donor cell. One gets
f
u U u
f u U u
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For large total glucose intakes, the donor cell excretes more lactate than necessary for bare survival 
of the acceptor cell, which can produce any amount of ATP as long as it is larger than fATP
min. The metabolic 
state of the acceptor cell is therefore not uniquely defined. When UG ≥ uG,2, for the fluxes of the acceptor 
cell one finds
f f
f
38 22LDH don LDH acc
ATP
min
− ≤ ≤ − ( ), ,
f f 23ox acc LDH acc= − , ( ), ,
while the ATP production is given by
= − . ( ), ,f f18 24ATP acc LDH acc
Note that fLDH,acc < 0 because the acceptor cell intakes lactate and reverses LDH.
The solution to this model is described pictorially in Fig.  2 and discussed in Fig.  3, where we also 
show the feasible range of values of the fluxes of the acceptor cell. In essence, this coarse-grained model 
suggests that an imbalance in the energetic demands of two cells can induce a metabolic coupling driven 
by a lactate shuttle from the high- to the low-demand cell, and provides a qualitative scenario for how 
carbon utilization in both cells changes by tuning the overall glucose supply. We shall now see that such 
a picture is fully recovered within a large-scale model of human metabolism.
Metabolic fluxes and crowding constraint in a cell-autonomous large scale metabolic net-
work. In order to characterize the exchange of carbon equivalents among interacting cells more in 
detail, we have analyzed a human metabolic network derived from the reconstructed human reactome21, 
to which we refer as the ‘Human Core Catabolic Network’ (HCCN, see ‘Materials and Methods’). The 
HCCN is composed by 67 metabolites and 75 reactions (including uptake fluxes), 23 of which are revers-
ible. The crowding constraint that accounts for finite cellular resources is represented as
( )+ + + ≤ Φ ( )a f a f f a f 25glyc HEX ox PDH GLUN LDH LDH ATP
where fHEX denotes the Hexokinase-1 flux, which irreversibly channels glucose into glycolysis, fPDH 
denotes the flux through pyruvate dehydrogenase, by which pyruvate is diverted into the TCA cycle and 
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fGLUN denotes the mithocondrial flux of nitrogen metabolism through glutaminase. We explore the space 
of flux patterns consistent with the constraints by sampling solutions of the mass balance equations Sf = 0 
(S denoting the stoichiometric matrix and f being a flux vector) such that flux vectors fdon of the donor 
cell appear with probability
P A ff exp 26don ATP donβ( ) =




, ( ),
where β ≥ 0 is a parameter and A is a normalization constant. The rationale is that, by tuning the value 
of β, we can pass from an unbiased sampling in which fATP,don takes on every allowed value with uniform 
probabilty (β = 0) to one in which the donor cell maximizes its ATP output (β → ∞), thereby obtaining 
a complete and refined picture of how different degrees of optimization by the donor cell impact the 
flux pattern of the acceptor cell. Solutions at the two extremes can be obtained with standard methods, 
as linear programming, but only our method allows us to sample realistic sub-optimal optimizations. In 
Fig. S6 we show how the ATP production increases as a function of β. In the following, as a prototype 
for sub-optimal optimization, we choose β = 5 that corresponds to roughly 70% of the maximum ATP 
production. Model and algorithmic details are discussed in ‘Materials and Methods’.
In Fig. 4a we show the ATP production of a single HCCN cell as a function of the available glucose. 
If ATP production is maximized (large β), one first encounters a regime with a yield of roughly 30 ATPs 
per glucose molecule (to be compared with the theoretical value of 38) and then a regime where the yield 
is about 1.7 ATPs per glucose. ATP is produced by OXPHOS in the former case, and by fermentation 
in the latter (see also Fig.  4b and Fig.  4c). As expected, networks maximizing ATP shift their meta-
bolic strategy at the glucose intake for which the resources available for ATP production by oxidation is 
exhausted. Note that for β = 5 one obtains an ATP efficiency very close to optimal. Quite importantly and 
surprisingly, however, for β = 0 (i.e. when no ATP maximization is performed) the emerging picture is 
qualitatively preserved, albeit with lower ATP yields. Indeed solutions sampled at β = 0 appear to employ 
a mixture of OXPHOS and fermentation even at low glucose intakes. It is remarkable that the resources 
-driven shift still occurs at uG, as in this case it corresponds to a largely suboptimal value of ATP pro-
duction. In other words, the HCCN might devote cellular resources to increase ATP production, but to 
do so it must explicitly be pursuing ATP maximization. This implies that the crossover from a high- to 
a low-yield strategy is a robust, embedded property of the network (and of the constraints imposed) and 
not an exclusive characteristic of the extremal solution that maximizes the ATP production.
Figure 2. Qualitative behaviour of the single-cell and of the donor-acceptor system for the coarse-
grained model. (a) In the cell-autonomous model, lactate overflow occurs when the glucose intake 
overcomes a threshold. Correspondingly, the flux through oxidative metabolism increases until the threshold 
before slowly decreasing once the crowding constraint is saturated and fermentation sets in. (b) In the 
donor/acceptor system, the donor behaves essentially as an autonomous cell and the acceptor adapts to it. 
For low glucose intakes, it operates oxidative pathways at small rate. When the donor saturates the crowding 
constraint excreting lactate, the acceptor imports it and uses it at a substrate to increase the flux through 
oxidative metabolism.
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In Fig. 4b, we focus on the fluxes through PDHm and LDH, that indicate whether pyruvate is directed 
towards OXPHOS or fermentation. We see that high ATP yields are obtained by using OXPHOS exclu-
sively. The typical network state at β = 0 is less efficient at all glucose intakes, as it always diverts a larger 
fraction of pyruvate to fermentation compared to the ATP-maximizing cell. Finally, in Fig. 4c, we detail 
how glucose partitions between fermentation and OXPHOS. The network displays a reversal of glucose 
fate as the crowding constraint is saturated independently of whether ATP production is being maxi-
mized or not. The latter case however turns out to be generically less efficient.
Metabolic fluxes in a large scale metabolic network of two cells coupled via a lactate shut-
tle. We now consider two replicas of the HCCN and again distinguish between a lactate acceptor and 
a donor cell. We also impose that there is no external lactate source, and explore the scenario where the 
donor optimizes ATP production to a degree tuned by the parameter β. Fig. 5a shows that, as expected, 
an ATP-maximizing donor cell sequesters all of the available glucose except for the small amount required 
for the acceptor’s survival. This is reflected by the ATP production curves as a function of the total glu-
cose supply displayed in Fig. 5b. In such conditions, the acceptor’s ATP production fluxes matches the 
minimum required for survival, i.e. f TPA
min (which is set to be equal to 1 uG for simplicity) until the donor 
switches to aerobic glycolysis, thereby excreting lactate. The donor, on the other hand, goes through an 
initial phase of exclusive OXPHOS use, followed by a switch to aerobic glycolysis when the crowding 
constraint does not allow for a further increment of the mitochondrial flux. In Fig. 6a one indeed sees 
that glucose is mainly channeled to OXPHOS as long as the crowding constraint allows for it. As soon 
as the latter is saturated, the donor diverts pyruvate to LDH, usefully regenerating NAD from NADH 
and thus avoiding glycolysis halt. LDH generates lactate, which is then expelled and intaken by the 
acceptor. As shown in Fig. 6b, this is accompanied by a reversal of LDH in the acceptor: lactate is trans-
formed into pyruvate that is then channeled to OXPHOS through PDHm. The acceptor can thus spare 
Figure 3. Solution of the minimal model of two cells coupled via a lactate shuttle. A lactate donor cell 
that maximizes ATP production is coupled to an acceptor cell. (a) Glucose intake for donor and acceptor as 
a function of total glucose supply. (b) ATP production as a function of the total glucose supply. The shaded 
area indicates that all values within that region are feasible. (c) Flux through fermentation fLDH (circles) 
and oxidative phosphorylation fox (crosses) as a function of the total glucose supply. (d) Fraction of ATP 
produced via fermentation (black) or via oxidative phosphorylation (red) in the donor cell as a function of 
the total ATP it produces.
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Figure 4. An isolated HCCN maximizes the ATP yield by directing glucose to OXPHOS even in absence 
of an active ATP maximization. (a) Average ATP production as a function of the re-scaled average glucose 
supply. (b) Average flux through LDH (crosses) and PDHm (circles) as a function of the re-scaled average 
glucose supply. (c) Fraction of ATP produced via glycolysis (crosses) or via OXPHOS (circles) as a function 
of the re-scaled total ATP produced. The flux through each pathway is re-scaled by half the amount of 
glucose intaken by the cell (because with one molecule of glucose cells produce two molecules of pyruvate). 
Curves describe the behaviour of an ATP-maximizing HCCN (black lines, β = 50), a loosely maximizing 
donor (red lines, β = 5) or the result of a uniform sampling of the allowed flux states for a HCCN (blue 
lines, β = 0). Error bars for the s.e.m. are smaller than symbols.
www.nature.com/scientificreports/
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some cellular resources to produce pyruvate, at the cost of becoming strongly dependent on the donor 
for ATP production.
If one instead averages over all solutions without biasing for ATP production by setting β = 0, the two 
cells produce comparable amounts of ATP and share glucose more evenly (see Fig. 5a). The fact that the 
donor turns out to employ slightly more glucose than the acceptor is due to the intrinsic asymmetry that 
is introduced by not letting the donor intake lactate. This asymmetry is also sufficient to drive, even when 
an unbiased statistical picture of the solution space is considered, a net lactate exchange as the typical 
behaviour Both cells, however, produce a factor 6 (roughly) less ATP than the maximum possible, given 
the glucose influx. Despite a similar overall ATP production profile, the internal fluxes of donor and 
acceptor differ significantly. While the donor distributes glucose almost evenly through LDH and PDHm, 
the acceptor can only generate ATP via OXPHOS, since it intakes lactate as an extra source of carbon. In 
Supplementary Fig. S1, we show that two symmetric cells with unbiased ATP production show identical 
glucose intake, ATP production, and internal flux distribution. Even for symmetric cells, however, when 
the donor optimizes the ATP production, we observe lactate shuttling between donor and acceptor cells, 
as illustrated again by Supplementary Fig. S1. In summary, for maximal ATP production (β → ∞) there 
is no difference between ATP production and internal flux distributions of symmetric and asymmetric 
cells-couples. For simplicity in the analysis of the data, we used the asymmetric case where the donor 
cell cannot intake lactate.
We observe that the fraction of ATP produced via oxidative phosphorylation utilized by the acceptor 
cell differs substantially from the one of the donor cell. In Fig.  4d we display the relative usage of the 
fermentative and the oxidative pathway and observe that, for low glucose supply, the acceptor cell only 
employs the oxidative pathway, independent of whether the donor cell maximizes ATP or not. When the 
donor cell maximizes ATP production, it sequesters most glucose and the acceptor cell is therefore forced 
to feed on lactate, which can only be usefully converted to ATP by means of OXPHOS. Conversely, when 
the donor cell does not maximize ATP production, it secretes a sizable amount of lactate because its 
metabolism is inefficient. The lactate acceptor, however, is also mainly feeding on glucose (see Fig. 5a) 
and could in principle secrete lactate just like the donor cell. The reason why a purely oxidative metabo-
lism is observed lies in the reversibility of LDH. Although lactate intake by the acceptor is small, it suf-
fices to force the pyruvate flux towards TCA and OXPHOS, thereby making the acceptor more efficient 
than the donor in energetic terms.
In order to assess the robustness of the occurrence of lactate overflow metabolism under the imposed 
constraints, we have further analyzed the flux configurations in a dono/acceptor system in which the 
donor maximizes the production of biomass precursors. We show here (see Fig. 7) results obtained by 
maximizing the biomass defined as in Table S9, which essentially reproduce those described above. Such 
a robustness becomes less surprising in the light of the fact that the qualitative features of the switch from 
oxidative to non-oxidative metabolism are obtained even in an unbiased sampling of the steady states. 
Figure 5. When a lactate donor maximizes its ATP production it intakes most of the glucose supplied 
to the two-cell system. The ATP production by the acceptor cell increases in correspondence to a decrease 
in efficiency of the donor’s metabolism. (a) Glucose intakes for two coupled cells as a function of the total 
glucose available to the donor-acceptor pair. (b) ATP produced by the donor. Curves describe the behaviour 
obtained for two coupled HCCN cells with an ATP-maximizing donor (black lines, β = 50), a loosely 
maximizing donor (red lines, β = 5) or for an unbiased sampling of the two-cell solution space (blue lines, 
β = 0). Error bars for the s.e.m. are smaller than symbols.
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This observation suggets that such a scenario is to a large degree embedded in the stoichiometry and in 
the main topological features of the underlying reaction network.
Correlation coefficients among metabolic fluxes of two cells coupled by lactate shuttle under 
glucose limitation. To formally assess the extent of metabolic coupling between an ATP-maximizing 
lactate donor and a lactate acceptor, we computed the matrix of normalized Pearson correlation coeffi-
cients of each pair of fluxes in the solutions sampled for different levels UG of the glucose supplied to the 
system. The Pearson coefficient between random variables X and Y is defined as r = cov(X,Y)/(σX σY), 
where cov(X,Y) denotes their covariance and σX and σY stand for their respective standard deviations. r 
ranges from − 1 to 1 and quantifies the linear dependence of the two variables. More precisely, the linear 
correlation between variables X and Y is more positive the closer r is to 1, and more negative the closer 
r is to − 1, while X and Y can be considered uncorrelated if r 0 . For sakes of clarity, we have considered 
the correlations arising in a system formed by an ATP-maximizing lactate donor (large β) and a lactate 
acceptor. For smaller values of β correlations get weaker while maintaing the same qualitative structure. 
Fig. 8 displays three reduced correlation matrices (obtained for three different values of the overall glu-
cose supply) where only a small subset of fluxes (each presentative of a different biologically relevant 
pathway) appears. Full matrices for three choices of UG are instead shown in Figs. S3–S5.
Figure 6. Oxidative and fermentative fluxes in a donor-acceptor system. (a,b) Average flux through LDH 
(circles) and PDHm (crosses) as a function of the average glucose supplied to the two-cell system. (c,d) 
Fraction of ATP produced via glycolysis (circles) or via oxidative phosphorylation (crosses) as a function of 
the total ATP produced by the donor cell. Pathways are normalized by the “pyruvate-equivalent”, i.e. by the 
sum of lactate and half-glucose intakes. Curves describe the behaviour obtained for two coupled HCCN cells 
with an ATP-maximizing donor (black lines, β = 50), a loosely maximizing donor (red lines, β = 5) or for an 
unbiased sampling of the two-cell solution space (blue lines, β = 0). Error bars, which represents s.e.m., are 
smaller than symbol sizes.
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Intuitively, correlation patterns should depend strongly on UG. The essence of this dependence, which 
clearly emerges from Fig. 8, is that cross-correlations between donor and acceptor build-up as the glucose 
supply increases, are maximal when the acceptor’s energetics depends on donor-derived lactate, and then 
decrease again rapidly to zero when the glucose supply is large enough to sustain both cells.
If UG is low (sub-threshold for lactate overflow), the ATP-maximizing donor necessarily outcompetes 
the acceptor for the available glucose, establishing a degree of cross-correlations that is driven mainly by 
the unbalanced nutrient partitioning. The donor indeed employs OXPHOS almost exclusively, while still 
leaking out a small amount of lactate which is taken up by the acceptor (i.e. there is no accumulation 
in the tissue). This suffices to establish the overall correlation among cells that can be seen in Fig. 8a.
As the glucose supply is increased further (above threshold for lactate overflow), the ATP-maximizing 
donor switches to aerobic glycolysis and secretes lactate that is shuttled to the acceptor in large amounts 
(viz. the strong negative correlation arising between the donor’s lactate outflux and the acceptor’s lactate 
influx). In such conditions, the overall cross-correlations increase, see Fig.  8b. In particular, glycolytic 
fluxes in donor and acceptor anti-correlate, oxidative pathways weakly anti-correlate, while te donor’s 
biosynthetic pathways correlate weakly with the acceptor’s oxidative pathways. Notice also that ATP flux 
in the donor weakly anticorrelates with every pathway in the acceptor’s metabolism.
At high enough UG, finally, cross-correlations decay as both cells can rely entirely on glucose for their 
energetics. Because the maximum glucose uptake for an HCCN is given by U a a2G
max
ATP G LDH= Φ /( + ) 
(this is determined by the crowding constraint (25) when glucose is entirely channeled to fermentation, 
i.e. when fHEX = UG,don = fLDH/2), one may assume that UG is “large enough” when it is larger than U2 G
max, 
as both cells would in this case have access to as much glucose as they can intake. In this case, no 
donor-acceptor correlations should be expected. Fig. 8c shows that this is indeed the case: intra-cellular 
correlations, described by the diagonal blocks, greatly exceed inter-cellular ones (off-diagonal blocks).
In summary, when glucose availability is limited, the fast-growing donor necessarily outcompetes the 
acceptor for glucose and a network of cross-correlations is established between the metabolic systems 
of the two cells. Metabolic pathways in donor and acceptor correlated however most strongly when a 
lactate exchange from donor to acceptor is established, and decay again as the two cells become effec-
tively decoupled in glucose-rich media. The build-up of a metabolic partnership is perhaps best seen 
by the fact that the donor’s glucose influx UG,don develops a correlation with the acceptor’s LDH flux at 
intermediate values of UG. Note also that UG,don correlates more and more strongly with the donor’s LDH 
flux as UG increases.
Discussion
Experimental evidence on lactate shuttles in cancer. While lactate shuttling is a likely scenario 
in many physiological conditions, from muscle cells undergoing intense activity22 to neuron-glia ener-
getics23–26, and has been reported to take place intra-cellularly at the mitochondrial and peroxisomal 
membrane22, no direct measurement of inter-cellular lactate exchange in cancer exists. Strong indirect 
evidence, however, suggests that such a scenario is indeed plausible.
Indeed, tumor-stroma and tumor-tumor metabolic interactions are currently being charac-
terized at various levels. The emerging picture increasingly suggests that cancer sustainment is a 
non-cell-autonomous phenomenon27–30 and that stromal cells might be potential targets for cancer treat-
ment31. Lactate exchange in particular has been investigated both as fueling oxidative cancer cells and as 
Figure 7. Donor’s biomass flux and lactate overflow, and acceptor’s lactate intake for two coupled 
HCCNs with a biomass-maximizing donor. The qualitative behavior obtained when the donor is 
maximizing the ATP flux is reproduced in a more realistic case in which a biomass objective function is 
considered. See Table S9 for the biomass coefficients.
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Figure 8. Restricted matrices of Pearson correlation coefficients for two coupled HCCN cells when the 
lactate donor maximizes the ATP production and the overall glucose supply is large shows that the two 
cells are not correlated. The intensity of the color represents the magnitude of the correlation coefficient 
(see scale on the right hand side). The two cells can independently access glucose and internal fluxes of 
the lactate acceptor and donor are essentially uncorrelated. The four representative reactions displayed for 
each cell are the glucose influx (Glc, a proxy for glycolytic activity), LDH (a proxy for lactate overflow and 
exchange), PDH (a proxy for oxidative metabolism) and the ATP production flux (ATP).
www.nature.com/scientificreports/
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supporting non-aberrant cancer-associated cells32,33. The latter case corresponds to the model discussed 
here. Signatures of tumor-to-stroma lactate shuttle have been reported in terms of the over-expression of 
monocarboxylate lactate transporters jointly with increased PDH activity in cancer-associated fibroblasts 
(CAFs)19,34. Likewise, tumor-derived lactate has been found to play a major signaling role (specifically, for 
the initiation of tumor angiogenesis) in vascular endothelial cells35. Inhibition of the lactate transporter 
MCT1 has therefore been proposed as a possible anti-angiogenic strategy36.
Taken together, these observations suggest that tumor cells and their associated stromal and vessel 
cells can be seen as a collective, synergistic metabolic unit where each compartment carries out comple-
mentary functions reflected in their energetic strategies. In such a microenvironment, aerobic stromal 
cells serve an essential ‘bioremediative’ role by removing potentially toxic compounds, thereby reducing 
acidity and positively feeding back on anaerobic cancer growth. The existence of a consistent imbalance 
in energetic demands across different compartments is crucial to establish this scenario.
Intercellular shuttling of lactate towards oxidative cancer cells is known to occur in two distinct 
forms, namely either from non-oxidative (e.g. hypoxic) to oxidative tumor cells36 or through the ‘reverse 
Warburg effect’, i.e. the onset of aerobic glycolysis in CAFs37–41. The former case describes the metabolic 
sysmbiosis that is established e.g. between more and less hypoxic regions of a tumor, which putatively 
allows glucose to be delivered more efficiently to more hypoxic regions42 (see43 for a game-theoretic 
approach to modeling this kind of tumor-tumor interplay). In the latter scenario, cancer cells induce 
oxidative stress in CAFs, resulting in CAFs switching to anaerobic glycolysis44. The secreted lactate is 
then imported by cancer cells for use in aerobic pathways. This effect has indeed been observed in 
vitro39,41, and its relevance in vivo is currently under scrutiny38. Clearly, however, this type of shuttling 
is not necessarily triggered by a strong imbalance in energetic demands between the lactate donor and 
acceptor cells, and different constraints in metabolic activity are likely to be required to understand its 
origin within genome-scale models.
It is worth noting that recently developed microfluidic platforms allow to probe the tumor microen-
vironment with unprecedented resolution and control over nutrient supply45. More light will hopefully 
be shed on its activity as a functional metabolic assembly and on the role of lactate in specific.
Going beyond cancer, however, such studies highlight the fact that replacing the natural environment 
in which cells live with a cell culture that is possibly optimized for the cell’s needs might severely limit 
our ability to understand the actual behavior of the system in vivo. On the other hand, they suggest that 
cell-autonomous models may be unable to capture some essential features of the energetics of cells: when 
cells employing different energetic demands share a limited resource, a mutually beneficial microenvi-
ronment characterized by a large-scale exchange of chemical species can be established. A thorough 
understanding of cellular growth strategies should take these aspects into account.
Conclusions
In this article we have studied the lactate-driven coupling that is established between cells with differ-
ent energetic requirements, showing that a lactate shuttle appears robustly as a consequence of basic 
physico-chemical constraints. Our model covers time scales over which the cellular metabolic networks 
have to adapt to the establishment of an imbalance in energy demands (as well as, for instance, in the 
levels of main carbon transporters), which are much shorter than the time required to alter the nutrient 
availability profile significantly (e.g. via vascularization). We have illustrated the emergent metabolic 
interaction scenario in a simplified model that captures the essential fact that, for two such cells, recy-
cling fermentation products may be a good strategy to optimize cellular glucose usage. To reach these 
conclusions, we have considered a human metabolic network model of cells interacting via lactate shuttle 
and sampled its feasible metabolic states according to a prescribed probability distribution by which we 
can tune the degree to which one of the two cells is pushing its ATP production. The scenario obtained in 
a highly simplified (but exactly solvable) model is fully retrieved in this case, where a thorough analysis 
of correlation patterns reveals further details of the cell-to-cell coupling.
Such a coupling would have serious physiological implications. First, lactate recycling implies that 
lactate may accumulate in tissues only in late-stage tumors. Before neighboring cells saturate their pro-
cessing capabilities, the lactate expelled by cancer cells would be taken in by non-aberrant cells, suggest-
ing that localized lactate measurements might identify early-stage tumors. Second, lactate shuttling and 
recycling systems should be regarded as potential targets for treatment.
There are many aspects of the approach presented here that can be further dissected. First is the 
nature of constraints. From a physical point of view, imposing “volume” constraints of the type consid-
ered here is equivalent to imposing finite flux capacities on energy-efficient pathways. There are however 
strong indications that unicellular organisms actively down-regulate energy-efficient pathways at high 
nutrient levels46,47. The fact that cells invest energy and resources in silencing the synthesis of enzymes 
involved in aerobic pathways suggests that the switch to an energy-inefficient pathway provides a real, 
physiological advantage for the cell. Its origin and nature are currently not understood, although the 
inclusion of additional “costs” due to regulation in metabolic models strongly suggests that the observed 
phenomenology can be captured, at least to some degree, by accounting for the fact that a shift in ener-
getic strategy requires a sizeable change of a cell’s protein repertoire1.
It is also important to note that the ETC in eukaryotes takes place in a separate cellular compartment 
(the mitochondrion), at odds with prokaryotes like bacteria, where it occurs is the cell’s periplasm. We 
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have entirely neglected the complications due to spatial organization, which is reasonable as long as 
one wants to focus on the ATP yield of energy-producing strategies. However, this aspect will become 
important for higher-resolution modeling at genome scale. Likewise, a more refined spatial modeling will 
allow for an in silico analysis of a possible role of intra-cellular lactate shuttling in cancer22. In brief, the 
key idea behind this is that glycolysis-derived lactate could be employed directly as an additional energy 
source for mitochondrial oxidation instead of being excreted. Elementary biochemical properties of the 
LDH reaction indeed would appear to favour lactate (rather than pyruvate) production in the cytosol. 
Moreover, experimental facts indicate a possible role of intra-cellular lactate shuttling in cardiomyocites, 
neurons and skeletal muscle cells facing high energy demands48. Accounting for it in a computational 
scheme may help reveal novel details about possible pathways of energy production during physical 
exercise or in rapidly growing cells.
Furtermore, while this work has focused on lactate as a key mediator of metabolic, energy-driven 
intercellular interactions, it is worth stressing that recent studies focusing on the comprehensive analysis 
of the exometabolome of growing cells has revealed that metabolic interactions encompass many more 
chemical species and is tightly coupled with the growth regime. In bacteria, for instance, released interme-
diates include not only carbon equivalents (like acetate, pyruvate and ethanol) but also amino acids and 
central metabolic intermediates [like fructose-6-phosphate, glucose-6-phosphate, 2/3-phosphoglycerates, 
phosphoenolpyruvate, acetyl-CoA, citrate and α-ketoglutarate], higher amounts of which have been 
found to be consistently released when carbon availability is high, while intermediates are typically 
in-taken in carbon-limitation2. Similar interactions are now known to occur in cancer: leukaemia cells 
have indeed been recently shown to employ cysteine derived from bone-marrow stromal cells as a means 
to fight oxidative stress29. As the scenario underpinning the establishment of such couplings is increas-
ingly elucidated, it will become possible to set up more refined and realistic models to capture a greater 
extent of their physiological relevance.
Finally, it should be kept in mind that aerobic glycolysis in cancer cells, especially at later stages of 
oncogenic development, could be due to the fact that the tumor microenvironment is hypoxic. The 
model we consider here addresses a faster time scale, over which the energy balance of neighbouring 
cells disrupts while the overall amount of resources available remains (roughly) unchanged, and suggests 
that at these stages tumor-to-stroma metabolic interactions can provide a mutually beneficial solution 
to the imbalance. It is also worth mentioning that cases are known in which malignant cells rely on 
increased oxidative phosphorylation rather than on aerobic glycolysis for energy production (as found, 
for instance, in transformed human mesenchymal stem cells5). Taken together, these results suggest that 
cancer’s bioenergetics, starting with the aerobic glycolysis versus oxidative phosphorylation “dilemma”, 
may be a dynamically modulated process that differs widely across tumor types49.
The modeling approach discussed here, based on exploring the solution space induced by mass-balance 
equations rather than on optimizing a prescribed objective function, is in our view the most suited 
to deal with multi-cell systems in which extended cell-to-cell metabolic interactions are established by 
one cell’s deregulated metabolic demands. The sampling method employed here is scalable and easy to 
implement, providing a highly promising tool for further studies. It would in particular be important to 
analyze the emergence of these effects in full-fledged genome-scale models of specific cancers, as can be 
obtained e.g. by refining reconstructions of human metabolic networks with cancer expression data. The 
full complexity of metabolic cell-to-cell interactions has only just started to be uncovered. Understanding 
its functional relevance by detailed in silico models may provide new insight into the mechanism of 
cancer progression and further advance the search of specific, targeted treatments. It would be impor-
tant to assess the relevance of lactate shuttling in the context of tumors through experiments probing 
metabolism (or metabolite exchanges) directly, rather than by collecting indirect evidence in the up- or 
down-regulation of specific transporters, and metabolic solution space sampling is known to provide 
useful keys for experiment design50. Our results indicate at least two potential ways to obtain useful 
information. One possibility requires setting up an assay where the ability of non-aberrant cells to intake 
lactate can be modulated in the presence of bona-fide lactate-secreting cancer cells. Such a modulation 
could be achieved, for instance, by either varying the relative concentration of donor- and acceptor-cells, 
or by changing the expression of lactate and glucose transporters in supporting cells. It is reasonable to 
expect that, in such a setup, the extracellular acidification rate due to the accumulation of lactate in the 
extracellular medium should negatively correlate with the lactate removal capacity of the supporting 
cells. On the other hand, results from our statistical sampling of the solution space suggest that different 
pathways (and hence, likely, the expression levels of different enzymes) should be tuned in a specific 
way by changing the overall glucose supply in a mixed culture shared by aberrant and non-aberrant 
cells. Monitoring expression levels in different, controlled nutrient conditions would therefore provide 
key validation to the coupling picture discussed here (and, more generally, to any cell-to-cell coupling 
scenario for cancer sustainment).
Materials and Methods
Human core catabolic network for a single cell. We built a realistic metabolic network of ATP 
production from the decompartmentalized human reactome Recon-121 that we use throughout the 
manuscript. (While the more recent Recon-2 reactome51 provides a higher resolution reconstruction of 
human metabolism, the degree of detail provided by Recon-1 more than suffices for our purposes.) The 
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HCCN includes the following Recon-1 pathways: Glycolysis, Pentose Phosphate Pathway, Citric Acid 
Cycle, and Oxidative Phosphorylation. In addition, we included anabolic pathways for the production of 
biomass precursors (amino acids and fatty acids) in an effective way. Details of the reconstructed network 
are given in Supporting Text S1. We then proceeded by removing the leaves of the resulting network (a 
necessary pre-processing step required to implement the mass-balance constraints described below). To 
rid the model of a priori infeasible loops, we resorted to the method described in52. A single infeasible 
cycle was identified, which was fixed by leaving only one of the two isoforms of the isocitrate dehydro-
genase that uses NADP as cofactor.
The final HCCN we employed in this study is composed of 67 chemical species (listed in Table S2) 
and 75 reactions (listed in Tables S3 and S4), including the uptake/secretion of 11 metabolites (namely 
molecular oxygen, carbon dioxide, water, hydrogen, lactate, glucose, ammonia, phenylalanine, methio-
nine, glutamine, and methyl group-which represents a generic methylation-whose bounds are fixed as 
described in Table S5), and reactions consuming ATP, aminoacids and palmitic acid. Among intracellu-
lar reactions, 23 are reversible according to Recon-1’s thermodynamic assignments. We have considered 
a medium with variable maximum glucose intake, fixed maximum glutamine intake and unbounded 
oxygen availability. Finally, ATP consumption presents a lower bound standing for the minimum ATP 
consumption flux f TPA
min necessary for cell survival (the bounds of all reactions are listed in Table S6 and 
S7).
Human core catabolic network for two coupled cells. In order to analyze the coupling of two 
identical cells, we simply replicated the HCCN twice, the only difference lying in the uptake reaction for 
lactate. In specific, the lactate donor can only secrete lactate (through an irreversible reaction), while the 
acceptor can both excrete and import it. The coupling is ultimately determined by the partitioning of 
glucose and by the shuttling of lactate. The former is a shared resource, while the latter can be exchanged 
between the two cells: both cells can produce lactate, but there is no external source of lactate. We have 
included two further constraints for the sum of glucose and lactate flux of the donor-acceptor system, 
i.e., UG,don + UG,acc ≤ UG and ULAC,don + ULAC,acc ≥ 0 (see Table S8). As for a single HCCN, glucose can only 
be imported while lactate can only be excreted.
Crowding constraint for the human core catabolic network. The crowding constraint within the 
HCCN has been implemented as
( )+ + + ≤ Φ ( )a f a f f a f 27glyc HEX ox PDH GLUN LDH LDH ATP
where fHEX denotes the Hexokinase-1 flux, fPDH denotes the flux through pyruvate dehydrogenase, by 
which pyruvate is diverted into the TCA cycle, and fGLUN denotes the flux through glutaminase. For aglyc, 
aLDH and aPDH we use the numerical values given in14 for a coarse-grained model, since for unitary flux 
both fHEX and fox transport the same amount of carbons present in glucose, which is exactly what the 
effective fluxes defined in14 do.
Inequality (27) is valid for a cell that excretes lactate. When lactate can also be intaken, as occurs 
for the coupled HCCN cells, the flux through LDH can become negative. The more general form of the 
crowding constraint we consider is therefore
( )+ + + ≤ Φ . ( )a f a f f a f 28glyc HEX ox PDH GLUN LDH LDH ATP
For both the single HCCN and the two-HCCN models, we provide as supplementary materials files 
containing the lists of metabolites and reactions (with bounds), and the explicit expressions of each reac-
tion in the HCCN in terms of independent variables, which provide a full characterization of the solution 
space polytope. The files can also be downloaded from http://chimera.roma1.infn.it/SYSBIO, where an 
SBML file with the model and a text file with the stoichiometric matrix of the single cell HCCN are also 
made available. HCCN for a single cell has also been deposited in BioModels Database (biomodels.org) 
and assigned the identifier MODEL1506170000.
Representation of the solution space of constraint-based metabolic networks as a con-
vex polytope. In mass-balance setups, a set of reaction fluxes f = {  fr} (r = 1,…,N) describes a 
non-equilibrium stationary state if it satisfies the conditions
S f m M0 1
29r
N
rm r
1
∑ = , = , …, ,
( )=
with prescribed bounds f f fr r r≤ ≤
− +. (Clearly, the zero flux vector is excluded from these considera-
tions.) Here, Srm denotes the stoichiometric index of chemical species m (m = 1,…M) in reaction r. From 
a geometric viewpoint, (29) defines a convex polytope, while every point inside it represents a feasible 
flux configuration. In absence of criteria allowing to select specific flux vectors from the solution space 
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(e.g. via the maximization of an objective function), uniform sampling provides important information 
about average fluxes and correlations that not only describe the viable flux patterns in statistical terms, 
but may also give relevant guidelines for designing experiments53. When the dimension of the solution 
space is sufficiently small (typically around 10), Monte Carlo sampling, including straightforward rejec-
tion methods50, can be applied. At higher dimensions, instead, exceeding computing times require the 
use of more advanced techniques.
Dimensional reduction of the solution space. We are interested in sampling the solution space 
of (29) with S = {Srm} given by the HCCN with the prescribed probability measure defined in (26). 
Mass balance conditions constrain many of the 75 fluxes to be dependent on other variables. To explore 
efficiently the space of viable flux configurations, it is convenient to solve all such dependencies ana-
lytically and then sample the (much smaller) space spanned by independent fluxes. To begin with, we 
transformed S to its Reduced Row Echelon Form (RREF) through Gauss-Jordan elimination, which 
can be implemented by standard packages. Because the RREF of any matrix is unique, the RREF of 
the stoichiometric matrix applied to the reaction network uniquely represents the dependent fluxes as 
a function of the independent ones. The single-HCCN model turns out to have only 17 independent 
variables, while the two-HCCN version has 34. These numbers also represent the dimensions D of the 
respective solution space polytopes.
Hit-and-run method allows to sample convex polytopes efficiently. The Hit-and-Run (HR) 
method54,55 can uniformly and efficiently sample a convex polytope, provided one starts from a point 
inside it. The problem of finding such a point can be easily solved, e.g., via Motzkin relaxation52,56. In 
brief, HR builds a Markov chain in two steps. First, starting from a point inside the polytope, a random 
direction is extracted. Second, along this direction a new point is chosen uniformly at random inside the 
polytope. The scheme is then iterated starting from the new internal point. HR is efficient because once 
the random direction is generated the search space is reduced to a segment. In our implementation, we 
generate the random direction using the Marsaglia-Bray method57. To pick a point at random along the 
segment, instead, we first compute the two intersections with the polytope and then extract a uniform 
random number inside the segment identified by these two points on the line.
The Lovasz method speeds up the sampling of heterogeneous polytopes. The above proce-
dure, while fully exact, may however present a drawback in concrete cases. In fact, the mixing time of 
HR in convex domains scales as  D R r[ ]2 2( / )  Monte Carlo steps, where D is the spatial dimension of 
the polytope while r and R are, respectively, the radius of the maximum inscribed hypersphere and of 
the minimum circumscribed hypersphere58. It is clear that the R/r factor can increase convergence times 
dramatically for strongly heterogeneous polytopes. This is precisely the case for the space of feasible 
steady states in a large-scale metabolic network, where flux distributions can be so heterogeneous as to 
span 5 orders of magnitudes59–61. For the network analyzed here, the ratio between the ellipsoid’s longest 
and smallest axes turned out to be of order 104, leading to a condition number of order R2/r2 ≃ 108, a 
value that would render straightforward HR too expensive in terms of CPU time. To circumvent this 
ill-conditioning problem, we have resorted to a standard pre-processing step that identifies the ellipsoid 
that best approximates the shape of the polytope62. Extracting vectors uniformly on such an ellipsoid 
guarantees that the directions along the longer axis are chosen more often, thereby removing ill condi-
tioning. In quantitative terms, such a pre-processing gives HR a mixing time of  D[ ]7 2/  Monte Carlo 
steps, thus implying a fully polynomial scaling with D. After pre-processing the slowest HR mode was 
found to decorrelate in an affordable time of  104( ) Monte Carlo steps. Furthermore, the overall 
pre-processing time was negligible compared to the time spent for the actual solution space sampling, 
while the center of the ellipsoid provides an excellent starting point for the algorithm. For more details 
of this method we refer the reader to63.
A method for tuning the optimization of a given metabolic flux for constrained based meta-
bolic networks. HR is easily modified to sample points according to any given flux distribution P(f) 
by imposing that the selection of points along the segment takes place according to how the distribution 
P projects onto the chosen direction rather than uniformly. To modulate P via a linear function L(f) of 
the fluxes, it is convenient to use the Boltzmann distribution P(f) ∝ exp[βL(f)], where β ≥ 0 is an inter-
polation parameter. By varying β, one passes from an uniform sampling (corresponding to β = 0) to 
sampling flux configurations that maximize L(f) (corresponding to 1β  ). For the HCCN network 
studied here, the ATP production fATP is maximized using the above method with P(f) ∝ exp[βfATP]. The 
value of β for which fATP is effectively maximized can be determined numerically. In Fig. S6 we plot the 
ATP production as a function of the β for five different values of the maximal glucose available for two 
coupled HCCN cells. One sees that optimal fATP is already achieved when β ≃ 50.
To produce the graphs presented in Figs. 4–8 and S1–S6, we applied the Lovasz method to the reduced 
row echelon forms of the HCCN networks and sampled the corresponding regularized polytopes by 
means of the Hit-and-run method. For curves with β ≠ 0, we used the Boltzman weight presented above. 
www.nature.com/scientificreports/
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The apply the Lovasz method and the uniform and optimized HR sampling, we used C+ + programs 
that we developed and that can be freely downloaded at http://chimera.roma1.infn.it/SYSBIO.
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